Alexander J Denner's Net Worth
$12.7 Million
Who is Alexander J Denner?
Alexander J Denner has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., ENZON PHARMACEUTICALS INC, Iterum Therapeutics plc, ADVENTRX PHARMACEUTICALS INC, APRICUS BIOSCIENCES, INC., Regulus Therapeutics Inc., Bioverativ Inc., Innoviva, Inc., ARIAD PHARMACEUTICALS INC, AMYLIN PHARMACEUTICALS INC, VIVUS INC, MEDICINES CO /DE, and IMCLONE SYSTEMS INC.
SEC CIK
Alexander J Denner's CIK is 0001361754
Past Insider Trading and Trends
2011 was Alexander J Denner's most active year for acquiring shares with 9 total transactions. Alexander J Denner's most active month to acquire stocks was the month of May. 2013 was Alexander J Denner's most active year for disposing of shares, totalling 13 transactions. Alexander J Denner's most active month to dispose stocks was the month of April. 2013 saw Alexander J Denner paying a total of $2,189,294.25 for 107,538 shares, this is the most they've acquired in one year. In 2013 Alexander J Denner cashed out on 81,850 shares for a total of $9,750,497.35, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.98% | 1.37K |
—
|
—
| 15.1K |
Jun 15
| |||
Form 4
| +5.98% | 775 |
—
|
—
| 13.73K |
Jul 1
| |||
Form 4
| +7.38% | 890 |
—
|
—
| 12.95K |
Jun 3
| |||
Form 4
| +10.59% | 1.16K |
—
|
—
| 12.06K |
Jun 19
| |||
Form 4
| +22.56% | 118.34K |
$229.94 | $27,211,823.50 | 643K |
Apr 30 - May 2
| |||
Form 4
| +13.60% | 62.8K |
$327.59 | $20,572,406.38 | 524.66K |
Jan 30 - Feb 1
| |||
Form 4
| +8.77% | 880 |
—
|
—
| 10.91K |
Jun 12
| |||
Form 4
| +11.60% | 48K |
$269.91 | $12,955,680.00 | 461.86K |
Apr 25
| |||
Form 4
| +7.82% | 30K |
$317.36 | $9,520,800.00 | 413.86K |
Nov 28 - Nov 29
| |||
Form 4
| +0.24% | 933 |
$316.56 | $295,350.48 | 383.86K |
Aug 31
| |||
Form 4
| +11.76% | 1.05K |
—
|
—
| 10.03K |
Jun 7
| |||
Form 4
| +23.83% | 73.86K |
$278.50 | $20,569,475.84 | 383.86K |
Apr 27
| |||
Form 4
| +13.43% | 1.06K |
—
|
—
| 8.95K |
Jun 8
| |||
Form 4
|
∞
| 310K |
$277.47 | $86,015,000.00 | 310K |
Oct 22 - Oct 23
| |||
Form 4
| +9.66% | 695 |
—
|
—
| 7.89K |
Jun 10
| |||
Form 4
| +13.75% | 870 |
—
|
—
| 7.2K |
Jun 12
| |||
Form 4
| -31.44% | -2.90K |
$212.00 | -$614,800.00 | 6.33K |
Scheduled
|
Jun 14
| ||
Form 4
| +16.48% | 1.3K |
—
|
—
| 9.22K |
Jun 12
| |||
Form 4
| +60.98% | 3K |
$53.43 | $160,290.00 | 7.92K |
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
$147.00 | -$7,106,693.10 | 4.92K |
Scheduled
|
May 28
| ||
Form 4
| -61.86% | -7.98K |
$148.62 | -$1,185,999.93 | 4.92K |
Scheduled
|
Dec 26 - Dec 27
| ||
Form 4
| +18.57% | 2.02K |
—
|
—
| 12.9K |
Jun 8
| |||
Form 4
| +36.71% | 2.9K |
—
|
—
| 10.8K |
Jun 1
| |||
Form 4
| +255.46% | 5.74K |
—
|
—
| 7.98K |
Jun 9
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.21% | 3.28K |
—
|
—
| 152.1K |
Sep 16
| |||
Form 4
| +19.53% | 24.31K |
—
|
—
| 148.82K |
Jun 18
| |||
Form 4
| +2.11% | 2.57K |
—
|
—
| 124.51K |
Jun 15
| |||
Form 4
| +1.38% | 1.66K |
—
|
—
| 121.94K |
Mar 15
| |||
Form 4
| +1.13% | 1.35K |
—
|
—
| 120.28K |
Dec 15
| |||
Form 4
| +1.54% | 1.8K |
—
|
—
| 118.93K |
Sep 15
| |||
Form 4
| +23.58% | 22.35K |
—
|
—
| 117.13K |
Jun 20
| |||
Form 4
| +1.45% | 1.36K |
—
|
—
| 94.78K |
Jun 15
| |||
Form 4
| +1.56% | 1.44K |
—
|
—
| 93.42K |
Mar 15
| |||
Form 4
| +1.37% | 1.24K |
—
|
—
| 91.98K |
Dec 15
| |||
Form 4
| +1.54% | 1.37K |
—
|
—
| 90.74K |
Sep 15
| |||
Form 4
| +1.39% | 1.22K |
—
|
—
| 89.37K |
Jun 15
| |||
Form 4
| +32.40% | 21.57K |
—
|
—
| 88.14K |
Jun 1
| |||
Form 4
| +1.76% | 1.15K |
—
|
—
| 66.57K |
Mar 15
| |||
Form 4
| +1.89% | 1.21K |
—
|
—
| 65.42K |
Dec 15
| |||
Form 4
| +1.80% | 1.14K |
—
|
—
| 64.21K |
Sep 15
| |||
Form 4
| +1.99% | 1.23K |
—
|
—
| 63.07K |
Jun 15
| |||
Form 4
| +58.26% | 22.77K |
—
|
—
| 61.84K |
Jun 2
| |||
Form 4
| +3.26% | 1.24K |
—
|
—
| 39.08K |
Mar 15
| |||
Form 4
| +1.39% | 225K |
$10.38 | $2,335,500.00 | 16.39M |
Mar 8 - Mar 10
| |||
Form 4
| +5.04% | 775K |
$10.01 | $7,758,750.00 | 16.16M |
Mar 3 - Mar 5
| |||
Form 4
| +9.62% | 1.35M |
$9.44 | $12,737,960.00 | 15.39M |
Feb 26 - Mar 2
| |||
Form 4
| +1.78% | 661 |
—
|
—
| 37.84K |
Dec 15
| |||
Form 4
|
∞
| 37.18K |
—
|
—
| 37.18K |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sarissa Capital Acquisition Corp. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +54.32% | 21.34K |
—
|
—
| 60.62K |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +60.22% | 14.76K |
—
|
—
| 39.28K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +135.03% | 14.09K |
—
|
—
| 24.52K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 10.43K |
—
|
—
| 10.43K |
May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||